NCT02974179View on ClinicalTrials.gov

A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

January 10, 2020

Study Completion Date

January 10, 2020

Conditions
Critical Limb Ischemia
Interventions
BIOLOGICAL

Subjects from Study AG-CLI-0206 who received AMG0001

Subjects from Study AG-CLI-0206 who received the study product AMG0001

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

AnGes USA, Inc.

INDUSTRY

NCT02974179 - A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia | Biotech Hunter | Biotech Hunter